{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:13:50Z","timestamp":1788754430626,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Deanship of Graduate Studies and Scientific Research at Jouf University","award":["DGSSR-2025-FC-01023"],"award-info":[{"award-number":["DGSSR-2025-FC-01023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11413-1","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:56:55Z","timestamp":1764079015000},"page":"5191-5206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational identification of Cucurbitacin S and Kammogenin as bioactive focal adhesion kinase 2 inhibitors for targeted cancer therapy"],"prefix":"10.1007","volume":"30","author":[{"given":"Salem Hussain","family":"Alharethi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma A. M.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleha Y. M.","family":"Alakilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelbaset Mohamed","family":"Elasbali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taj","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"11413_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm1549","volume":"6","author":"SK Mitra","year":"2005","unstructured":"Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6:56\u201368. https:\/\/doi.org\/10.1038\/nrm1549","journal-title":"Nat Rev Mol Cell Biol"},{"key":"11413_CR2","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.addr.2010.11.001","volume":"63","author":"X Zhao","year":"2011","unstructured":"Zhao X, Guan J-L (2011) Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev 63:610\u2013615. https:\/\/doi.org\/10.1016\/j.addr.2010.11.001","journal-title":"Adv Drug Deliv Rev"},{"key":"11413_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/gb-2007-8-5-215","volume":"8","author":"Y Takada","year":"2007","unstructured":"Takada Y, Ye X, Simon S (2007) The integrins. Genome Biol 8:215. https:\/\/doi.org\/10.1186\/gb-2007-8-5-215","journal-title":"Genome Biol"},{"key":"11413_CR4","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.3390\/polym13172950","volume":"13","author":"AA El-Rashidy","year":"2021","unstructured":"El-Rashidy AA, El Moshy S, Radwan IA, Rady D, Abbass MM, D\u00f6rfer CE et al (2021) Effect of polymeric matrix stiffness on osteogenic differentiation of mesenchymal stem\/progenitor cells: concise review. Polymers 13:2950. https:\/\/doi.org\/10.3390\/polym13172950","journal-title":"Polymers"},{"key":"11413_CR5","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1074\/mcp.m115.050484","volume":"14","author":"X Wu","year":"2015","unstructured":"Wu X, Zahari MS, Renuse S, Nirujogi RS, Kim M-S, Manda SS et al (2015) Phosphoproteomic analysis identifies focal adhesion kinase 2 (FAK2) as a potential therapeutic target for tamoxifen resistance in breast cancer. Mol Cell Proteom 14:2887\u20132900. https:\/\/doi.org\/10.1074\/mcp.m115.050484","journal-title":"Mol Cell Proteom"},{"key":"11413_CR6","doi-asserted-by":"publisher","first-page":"7567","DOI":"10.1038\/s41467-023-43419-4","volume":"14","author":"Y Lin","year":"2023","unstructured":"Lin Y, Yang J, Yang Q, Zeng S, Zhang J, Zhu Y et al (2023) PTK2B promotes TBK1 and STING oligomerization and enhances the STING\u2013TBK1 signaling. Nat Commun 14:7567. https:\/\/doi.org\/10.1038\/s41467-023-43419-4","journal-title":"Nat Commun"},{"key":"11413_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.14715\/cmb\/2022.68.1.4","volume":"68","author":"C Chen","year":"2022","unstructured":"Chen C, Tao Z, Li Y, Li J, Xu Y (2022) MicroRNA-214 expression inhibits HCC cell proliferation through PTK2B\/Pyk2. Cell Mol Biol 68:20\u201325. https:\/\/doi.org\/10.14715\/cmb\/2022.68.1.4","journal-title":"Cell Mol Biol"},{"key":"11413_CR8","doi-asserted-by":"publisher","first-page":"13193","DOI":"10.1074\/jbc.m809038200","volume":"284","author":"S Han","year":"2009","unstructured":"Han S, Mistry A, Chang JS, Cunningham D, Griffor M, Bonnette PC et al (2009) Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique DFG-out conformation and enables inhibitor design. J Biol Chem 284:13193\u201313201. https:\/\/doi.org\/10.1074\/jbc.m809038200","journal-title":"J Biol Chem"},{"key":"11413_CR9","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2007.05.041","volume":"129","author":"D Lietha","year":"2007","unstructured":"Lietha D, Cai X, Ceccarelli DF, Li Y, Schaller MD, Eck MJ (2007) Structural basis for the autoinhibition of focal adhesion kinase. Cell 129:1177\u20131187. https:\/\/doi.org\/10.1016\/j.cell.2007.05.041","journal-title":"Cell"},{"issue":"24","key":"11413_CR10","doi-asserted-by":"publisher","first-page":"5926","DOI":"10.1016\/j.bmcl.2016.10.092","volume":"26","author":"J Farand","year":"2016","unstructured":"Farand J, Mai N, Chandrasekhar J, Newby ZE, Van Veldhuizen J, Loyer-Drew J, Venkataramani C, Guerrero J, Kwok A, Li N, Zherebina Y, Wilbert S, Zablocki J, Phillips G, Watkins WJ, Mourey R, Notte GT (2016) Selectivity switch between FAK and Pyk2: macrocyclization of FAK inhibitors improves Pyk2 potency. Bioorg Med Chem Lett 26(24):5926\u20135930. https:\/\/doi.org\/10.1016\/j.bmcl.2016.10.092","journal-title":"Bioorg Med Chem Lett"},{"key":"11413_CR11","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1021\/acs.biochem.5b01274","volume":"55","author":"MS Vanarotti","year":"2016","unstructured":"Vanarotti MS, Finkelstein DB, Guibao CD, Nourse A, Miller DJ, Zheng JJ (2016) Structural basis for the interaction between Pyk2-FAT domain and leupaxin LD repeats. Biochemistry 55:1332\u20131345. https:\/\/doi.org\/10.1021\/acs.biochem.5b01274","journal-title":"Biochemistry"},{"key":"11413_CR12","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1016\/j.bmcl.2012.10.039","volume":"22","author":"SK Bhattacharya","year":"2012","unstructured":"Bhattacharya SK, Aspnes GE, Bagley SW, Boehm M, Brosius AD, Buckbinder L et al (2012) Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors. Bioorg Med Chem Lett 22:7523\u20137529. https:\/\/doi.org\/10.1016\/j.bmcl.2012.10.039","journal-title":"Bioorg Med Chem Lett"},{"key":"11413_CR13","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1016\/j.bmcl.2009.04.093","volume":"19","author":"DP Walker","year":"2009","unstructured":"Walker DP, Zawistoski MP, McGlynn MA, Li J-C, Kung DW, Bonnette PC et al (2009) Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity. Bioorg Med Chem Lett 19:3253\u20133258. https:\/\/doi.org\/10.1016\/j.bmcl.2009.04.093","journal-title":"Bioorg Med Chem Lett"},{"key":"11413_CR14","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.3390\/cancers17162611","volume":"17","author":"L Kucheryavykh","year":"2025","unstructured":"Kucheryavykh L, Kucheryavykh Y (2025) The role of Pyk2 kinase in glioblastoma progression and therapeutic targeting. Cancers 17:2611. https:\/\/doi.org\/10.3390\/cancers17162611","journal-title":"Cancers"},{"key":"11413_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tcb.2023.07.006","volume":"34","author":"H Gil-Henn","year":"2024","unstructured":"Gil-Henn H, Girault J-A, Lev S (2024) PYK2, a hub of signaling networks in breast cancer progression. Trends Cell Biol 34:312\u2013326. https:\/\/doi.org\/10.1016\/j.tcb.2023.07.006","journal-title":"Trends Cell Biol"},{"key":"11413_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ccell.2015.03.012","volume":"27","author":"MW K\u00fchn","year":"2015","unstructured":"K\u00fchn MW, Armstrong SA (2015) Designed to kill: novel menin-MLL inhibitors target MLL-rearranged leukemia. Cancer Cell 27:431\u2013433. https:\/\/doi.org\/10.1016\/j.ccell.2015.03.012","journal-title":"Cancer Cell"},{"key":"11413_CR17","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/s0140-6736(20)30164-1","volume":"395","author":"PL Bedard","year":"2020","unstructured":"Bedard PL, Hyman DM, Davids MS, Siu LL (2020) Small molecules, big impact: 20 years of targeted therapy in oncology. Lancet 395:1078\u20131088. https:\/\/doi.org\/10.1016\/s0140-6736(20)30164-1","journal-title":"Lancet"},{"key":"11413_CR18","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1158\/2159-8290.cd-18-1181","volume":"8","author":"C Aggarwal","year":"2018","unstructured":"Aggarwal C, Albelda SM (2018) Molecular characterization of malignant mesothelioma: time for new targets? Cancer Discov 8:1508\u20131510. https:\/\/doi.org\/10.1158\/2159-8290.cd-18-1181","journal-title":"Cancer Discov"},{"key":"11413_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.181","volume":"3","author":"GH Liu","year":"2022","unstructured":"Liu GH, Chen T, Zhang X, Ma XL, Shi HS (2022) Small molecule inhibitors targeting the cancers. MedComm 3:e181. https:\/\/doi.org\/10.1002\/mco2.181","journal-title":"MedComm"},{"key":"11413_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79:629\u2013661. https:\/\/doi.org\/10.1021\/acs.jnatprod.5b01055","journal-title":"J Nat Prod"},{"key":"11413_CR21","doi-asserted-by":"publisher","first-page":"7872","DOI":"10.1039\/D1RA09339H","volume":"12","author":"F Anjum","year":"2022","unstructured":"Anjum F, Sulaimani MN, Shafie A, Mohammad T, Ashraf GM, Bilgrami AL et al (2022) Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics. RSC Adv 12:7872\u20137882. https:\/\/doi.org\/10.1039\/D1RA09339H","journal-title":"RSC Adv"},{"key":"11413_CR22","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1080\/07391102.2023.2228912","volume":"42","author":"A Alam","year":"2024","unstructured":"Alam A, Khan MS, Mathur Y, Sulaimani MN, Farooqui N, Ahmad SF et al (2024) Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach. J Biomol Struct Dyn 42:5758\u20135769. https:\/\/doi.org\/10.1080\/07391102.2023.2228912","journal-title":"J Biomol Struct Dyn"},{"key":"11413_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa279","volume":"22","author":"T Mohammad","year":"2021","unstructured":"Mohammad T, Mathur Y, Hassan MI (2021) InstaDock: a single-click graphical user interface for molecular docking-based virtual high-throughput screening. Brief Bioinform 22:bbab279. https:\/\/doi.org\/10.1093\/bib\/bbaa279","journal-title":"Brief Bioinform"},{"key":"11413_CR24","volume-title":"Discovery studio visualizer 2","author":"D Visualizer","year":"2005","unstructured":"Visualizer D (2005) Discovery studio visualizer 2. Accelrys Software Inc., San Diego"},{"key":"11413_CR25","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano WL (2002) Pymol: an open-source molecular graphics tool. CCP4 Newsl Protein Crystallogr 40:82\u201392","journal-title":"CCP4 Newsl Protein Crystallogr"},{"key":"11413_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H et al (2000) The protein data bank. Nucleic Acids Res 28:235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"key":"11413_CR27","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"11413_CR28","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires DE, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"11413_CR29","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1007\/s11172-017-1954-x","volume":"66","author":"D Druzhilovskiy","year":"2017","unstructured":"Druzhilovskiy D, Rudik A, Filimonov D, Gloriozova T, Lagunin A, Dmitriev A et al (2017) Computational platform Way2Drug: from the prediction of biological activity to drug repurposing. Russ Chem Bull 66:1832\u20131841. https:\/\/doi.org\/10.1007\/s11172-017-1954-x","journal-title":"Russ Chem Bull"},{"key":"11413_CR30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/bioinformatics\/btw638","volume":"33","author":"G Janson","year":"2017","unstructured":"Janson G, Zhang C, Prado MG, Paiardini A (2017) PyMod 2.0: improvements in protein sequence-structure analysis and homology modeling within PyMOL. Bioinformatics 33:444\u2013446. https:\/\/doi.org\/10.1093\/bioinformatics\/btw638","journal-title":"Bioinformatics"},{"key":"11413_CR31","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","volume":"8","author":"R Vivek-Ananth","year":"2023","unstructured":"Vivek-Ananth R, Mohanraj K, Sahoo AK, Samal A (2023) IMPPAT 2.0: an enhanced and expanded phytochemical atlas of Indian medicinal plants. ACS Omega 8:8827\u20138845. https:\/\/doi.org\/10.1021\/acsomega.3c00156","journal-title":"ACS Omega"},{"key":"11413_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1:337\u2013341. https:\/\/doi.org\/10.1016\/j.ddtec.2004.11.007","journal-title":"Drug Discov Today Technol"},{"key":"11413_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0311954","volume":"20","author":"MN Sulaimani","year":"2025","unstructured":"Sulaimani MN, Ahmed S, Anjum F, Mohammad T, Shamsi A, Dohare R et al (2025) Structure-guided identification of mitogen-activated protein kinase-1 inhibitors towards anticancer therapeutics. PLoS ONE 20:e0311954. https:\/\/doi.org\/10.1371\/journal.pone.0311954","journal-title":"PLoS ONE"},{"key":"11413_CR34","doi-asserted-by":"publisher","first-page":"1492847","DOI":"10.3389\/fmolb.2024.1492847","volume":"11","author":"I Habib","year":"2024","unstructured":"Habib I, Sulaimani MN, Jairajpuri DS, Hussain A, Mohammad T, Alajmi MF et al (2024) Identification of potential bioactive phytochemicals for the inhibition of platelet-derived growth factor receptor \u03b2: a structure-based approach for cancer therapy. Front Mol Biosci 11:1492847. https:\/\/doi.org\/10.3389\/fmolb.2024.1492847","journal-title":"Front Mol Biosci"},{"issue":"3","key":"11413_CR35","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s11696-024-03869-6","volume":"79","author":"A Taiyab","year":"2025","unstructured":"Taiyab A, Mohammad T, Sulaimani MN, Anjum F, Azum N, Ashraf A, Rathi A, Hassan MI (2025) Structure-guided identification of potential MTH1 inhibitors from natural compounds: toward therapeutic targeting of oxidative DNA damage in cancer. Chem Pap 79(3):1477\u20131492. https:\/\/doi.org\/10.1007\/s11696-024-03869-6","journal-title":"Chem Pap"},{"key":"11413_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.139107","volume":"292","author":"A Rathi","year":"2025","unstructured":"Rathi A, Noor S, Sulaimani MN, Ahmed S, Taiyab A, AlAjmi MF et al (2025) FDA-approved drugs as PIM-1 kinase inhibitors: a drug repurposed approach for cancer therapy. Int J Biol Macromol 292:139107. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139107","journal-title":"Int J Biol Macromol"},{"key":"11413_CR37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00203-024-04192-0","volume":"206","author":"MU Saeed","year":"2024","unstructured":"Saeed MU, Ahmed S, Choudhury A, Hussain A, Alajmi MF, Mohammad T et al (2024) Discovering novel inhibitors of RfaH from Klebsiella pneumoniae to combat antimicrobial resistance. Arch Microbiol 206:472. https:\/\/doi.org\/10.1007\/s00203-024-04192-0","journal-title":"Arch Microbiol"},{"key":"11413_CR38","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth SA, Dror RO (2018) Molecular dynamics simulation for all. Neuron 99:1129\u20131143. https:\/\/doi.org\/10.1016\/j.neuron.2018.08.011","journal-title":"Neuron"},{"key":"11413_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9869-2_17","volume":"4","author":"S Patodia","year":"2014","unstructured":"Patodia S, Bagaria A, Chopra D (2014) Molecular dynamics simulation of proteins: a brief overview. J Phys Chem Biophys 4:1\u20136. https:\/\/doi.org\/10.1007\/978-1-4939-9869-2_17","journal-title":"J Phys Chem Biophys"},{"key":"11413_CR40","doi-asserted-by":"publisher","unstructured":"Hassan MI, Umair M, Mathur Y, Mohammad T, Khan A, Sulaimani MN, et al. (2023) Molecular dynamics simulation to study thermal unfolding in proteins. In: Protein folding dynamics and stability: experimental and computational methods. Springer, pp 221\u2013249. https:\/\/doi.org\/10.1007\/978-981-99-2079-2_12","DOI":"10.1007\/978-981-99-2079-2_12"},{"key":"11413_CR41","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.7638618","volume":"269","author":"SJ Hagen","year":"1995","unstructured":"Hagen SJ, Hofrichter J, Eaton WA (1995) Protein reaction kinetics in a room-temperature glass. Science 269:959\u2013962. https:\/\/doi.org\/10.1126\/science.7638618","journal-title":"Science"},{"key":"11413_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B et al (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"key":"11413_CR43","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1021\/ci300363c","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe K, MacKerell AD Jr (2012) Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing. J Chem Inf Model 52:3144\u20133154. https:\/\/doi.org\/10.1021\/ci300363c","journal-title":"J Chem Inf Model"},{"key":"11413_CR44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jmb.2008.10.018","volume":"385","author":"GG Maisuradze","year":"2009","unstructured":"Maisuradze GG, Liwo A, Scheraga HA (2009) Principal component analysis for protein folding dynamics. J Mol Biol 385:312\u2013329. https:\/\/doi.org\/10.1016\/j.jmb.2008.10.018","journal-title":"J Mol Biol"},{"key":"11413_CR45","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari R, Kumar R, Consortium OSDD, Lynn A (2014) g_mmpbsa: A GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54:1951\u20131962. https:\/\/doi.org\/10.1021\/ci500020m","journal-title":"J Chem Inf Model"},{"key":"11413_CR46","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.1073\/pnas.181342398","volume":"98","author":"NA Baker","year":"2001","unstructured":"Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A 98:10037\u201310041. https:\/\/doi.org\/10.1073\/pnas.181342398","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11413_CR47","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1080\/07391102.2019.1682052","volume":"38","author":"M Amir","year":"2020","unstructured":"Amir M, Mohammad T, Prasad K, Hasan GM, Kumar V, Dohare R et al (2020) Virtual high-throughput screening of natural compounds in-search of potential inhibitors for protection of telomeres 1 (POT1). J Biomol Struct Dyn 38:4625\u20134634. https:\/\/doi.org\/10.1080\/07391102.2019.1682052","journal-title":"J Biomol Struct Dyn"},{"key":"11413_CR48","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3390\/pharmaceutics13122157","volume":"13","author":"A Shafie","year":"2021","unstructured":"Shafie A, Khan S, Zehra MT, Anjum F, Hasan GM et al (2021) Identification of phytoconstituents as potent inhibitors of casein kinase-1 alpha using virtual screening and molecular dynamics simulations. Pharmaceutics 13:2157. https:\/\/doi.org\/10.3390\/pharmaceutics13122157","journal-title":"Pharmaceutics"},{"key":"11413_CR49","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.drudis.2019.10.014","volume":"25","author":"C-Y Jia","year":"2020","unstructured":"Jia C-Y, Li J-Y, Hao G-F, Yang G-F (2020) A drug-likeness toolbox facilitates ADMET study in drug discovery. Drug Discov Today 25:248\u2013258. https:\/\/doi.org\/10.1016\/j.drudis.2019.10.014","journal-title":"Drug Discov Today"},{"key":"11413_CR50","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","volume":"50","author":"D Filimonov","year":"2014","unstructured":"Filimonov D, Lagunin A, Gloriozova T, Rudik A, Druzhilovskii D, Pogodin P et al (2014) Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem Heterocycl Compd 50:444\u2013457. https:\/\/doi.org\/10.1007\/s10593-014-1496-1","journal-title":"Chem Heterocycl Compd"},{"key":"11413_CR51","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1089\/omi.2021.0059","volume":"25","author":"F Anjum","year":"2021","unstructured":"Anjum F, Ali F, Mohammad T, Shafie A, Akhtar O, Abdullaev B et al (2021) Discovery of natural compounds as potential inhibitors of human carbonic anhydrase II: an integrated virtual screening, docking, and molecular dynamics simulation study. OMICS 25:513\u2013524. https:\/\/doi.org\/10.1089\/omi.2021.0059","journal-title":"OMICS"},{"key":"11413_CR52","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1021\/acs.jcim.7b00017","volume":"57","author":"Y Yan","year":"2017","unstructured":"Yan Y, Wang W, Sun Z, Zhang JZ, Ji C (2017) Protein-ligand empirical interaction components for virtual screening. J Chem Inf Model 57:1793\u20131806. https:\/\/doi.org\/10.1021\/acs.jcim.7b00017","journal-title":"J Chem Inf Model"},{"issue":"4","key":"11413_CR53","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0006-3495(03)74687-6","volume":"85","author":"I Tavernelli","year":"2003","unstructured":"Tavernelli I, Cotesta S, Di Iorio EE (2003) Protein dynamics, thermal stability, and free-energy landscapes: a molecular dynamics investigation. Biophys J 85(4):2641\u20132649. https:\/\/doi.org\/10.1016\/S0006-3495(03)74687-6","journal-title":"Biophys J"},{"key":"11413_CR54","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.3390\/molecules27103060","volume":"27","author":"C Yang","year":"2022","unstructured":"Yang C, Alam A, Alhumaydhi FA, Khan MS, Alsagaby SA, Al Abdulmonem W et al (2022) Bioactive phytoconstituents as potent inhibitors of tyrosine-protein kinase yes (YES1): implications in anticancer therapeutics. Molecules 27:3060. https:\/\/doi.org\/10.3390\/molecules27103060","journal-title":"Molecules"},{"key":"11413_CR55","doi-asserted-by":"publisher","first-page":"439","DOI":"10.48309\/jcr.2023.407989.1235","volume":"5","author":"HS Samuel","year":"2023","unstructured":"Samuel HS, Nweke-Maraizu U, Etim EE (2023) Understanding intermolecular and intramolecular hydrogen bonds: spectroscopic and computational approaches. J Chem Rev 5:439\u2013465. https:\/\/doi.org\/10.48309\/jcr.2023.407989.1235","journal-title":"J Chem Rev"},{"key":"11413_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.70005","volume":"38","author":"A Taiyab","year":"2025","unstructured":"Taiyab A, Sulaimani MN, Rathi A, Khan F, Hussain A, Alajmi MF et al (2025) Repurposing FDA-approved drugs to target MTH1 for anticancer therapeutics. J Mol Recognit 38:e70005. https:\/\/doi.org\/10.1002\/jmr.70005","journal-title":"J Mol Recognit"},{"key":"11413_CR57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/07391102.2019.1705186","volume":"39","author":"M Amir","year":"2021","unstructured":"Amir M, Ahamad S, Mohammad T, Jairajpuri DS, Hasan GM, Dohare R et al (2021) Investigation of conformational dynamics of Tyr89Cys mutation in protection of telomeres 1 gene associated with familial melanoma. J Biomol Struct Dyn 39:35\u201344. https:\/\/doi.org\/10.1080\/07391102.2019.1705186","journal-title":"J Biomol Struct Dyn"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11413-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11413-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11413-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:39:17Z","timestamp":1783161557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11413-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11413"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11413-1","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing or conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}